Studies have shown that trinitrobenzene sulfonic acid (TNBS)-induced colitis is ameliorated by inhibiting MyD88 expression, which subsequently downregulates downstream caspase-3 expression (Miao et al., 2024). Here, MYD88 is linked to colitis.